Show simple item record

dc.contributor.authorLeeman, Alejandro Villar
dc.contributor.authorFitzsimons, Heather
dc.contributor.authorGreenblatt, Aaron D.
dc.contributor.authorRingwala, Aditi
dc.contributor.authorLiu, Tracy
dc.contributor.authorZimmermann, Hannah
dc.contributor.authorKonova, Anna
dc.contributor.authorTofighi, Babak
dc.contributor.authorMurphy, Sean
dc.contributor.authorRotrosen, John
dc.contributor.authorGlimcher, Paul
dc.contributor.authorBelcher, Annabelle M.
dc.date.accessioned2024-05-23T16:00:17Z
dc.date.available2024-05-23T16:00:17Z
dc.date.issued2024-05-06
dc.identifier.urihttp://hdl.handle.net/10713/22437
dc.descriptionKahlert Institute Inaugural Research Symposium. May 6, 2024.en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshXylazineen_US
dc.subject.meshOpioid-Related Disordersen_US
dc.subject.meshMortalityen_US
dc.titleXylazine-positive prevalence among people receiving medications for opioid use disorder: exploratory data from three urban settings in the Northeasten_US
dc.typePoster/Presentationen_US
refterms.dateFOA2024-05-23T16:00:18Z


Files in this item

Thumbnail
Name:
Leeman_Xylazine-positive-preva ...
Size:
2.079Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International